Sign Up Today and Learn More About Aphea.Bio Stock
Invest in or calculate the value of your shares in Aphea.Bio or other pre-IPO companies through EquityZen's platform.
Aphea.Bio Stock (APBI)
Aphea.Bio offers research and development in the areas of bioinsecticides and bioherbicides.
About Aphea.Bio Stock
Founded
2017
Industries
Software, Artificial Intelligence, Data and Analytics
Aphea.Bio Press Mentions
Stay in the know about the latest news on Aphea.Bio
Maria Rasputina on LinkedIn: ActivÂŽ by aphea.bio - biostymulator do zaprawiania nasion | SYNGENTA
linkedin ⢠May 24, 2024
The top 20 agtech deals of 2023
agfundernews ⢠Jan 19, 2024
Cutting-edge European startups that secured funding from Bill ...
techfundingnews ⢠Jan 19, 2024
Whereâs the money? These 15 food startups raised $700 ...
greenbiz ⢠Dec 23, 2023
The Netherlands' SMART Photonics beams in âŹ100 million
tech ⢠Dec 23, 2023
Aphea.Bio Management
Leadership team at Aphea.Bio
CEO & co-founder
Isabel Vercauteren
Join now and verify your accreditation status to gain access to:
- Aphea.Bio current valuation
- Aphea.Bio stock price
- Available deals in Aphea.Bio and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Aphea.Bio stock?
Accredited investors can buy pre-IPO stock in companies like Aphea.Bio through EquityZen funds. These investments are made available by existing Aphea.Bio shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event â house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Aphea.Bio stock?
Shareholders can sell their Aphea.Bio stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
